• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients.

作者信息

Borgogna Cinzia, Bruna Riccardo, Griffante Gloria, Martuscelli Licia, De Andrea Marco, Ferrante Daniela, Patriarca Andrea, Mahmoud Abdurraouf Mokhtar, Ucciero Maghalie Anais Marie, Gaidano Valentina, Marchetti Monia, Rapezzi Davide, Lai Michele, Pistello Mauro, Ladetto Marco, Massaia Massimo, Gaidano Gianluca, Gariglio Marisa

机构信息

Virology Unit, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.

Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale and "Maggiore della Carità" Hospital, Novara, Italy.

出版信息

Br J Haematol. 2022 Nov;199(3):463-467. doi: 10.1111/bjh.18429. Epub 2022 Sep 5.

DOI:10.1111/bjh.18429
PMID:36062472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9538857/
Abstract
摘要

相似文献

1
Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients.在既往感染过的血液系统癌症患者中接种疫苗后诱导针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的强大体液免疫。
Br J Haematol. 2022 Nov;199(3):463-467. doi: 10.1111/bjh.18429. Epub 2022 Sep 5.
2
Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.接种 COVID-19 mRNA 疫苗后，需要数天才能诱导针对 SARS-CoV-2 的高特异性体液和细胞反应。
Front Immunol. 2021 Oct 4;12:726960. doi: 10.3389/fimmu.2021.726960. eCollection 2021.
3
Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy.mRNA 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫在接受生物治疗的重症哮喘患者中的有效性和持久性。
Front Immunol. 2022 May 20;13:892277. doi: 10.3389/fimmu.2022.892277. eCollection 2022.
4
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.在真实环境中评估灭活 COVID-19 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫应答的特征。
Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.
5
Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation.先前感染 SARS-CoV-2 后接种 ChAdOx1 nCoV-19 对 COVID-19 的保护免疫：体液和细胞研究。
Viruses. 2022 Aug 30;14(9):1916. doi: 10.3390/v14091916.
6
Study of humoral and cellular immunity in vaccinated with mRNA-1273.mRNA-1273 疫苗接种者体液和细胞免疫研究。
APMIS. 2022 May;130(5):261-269. doi: 10.1111/apm.13215. Epub 2022 Mar 3.
7
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity.一种双抗原自扩增 RNA SARS-CoV-2 疫苗可诱导强烈的体液和细胞免疫应答，并通过 T 细胞介导的免疫来预防 SARS-CoV-2 变体。
Mol Ther. 2022 Sep 7;30(9):2968-2983. doi: 10.1016/j.ymthe.2022.04.014. Epub 2022 Apr 20.
8
Antigen Specific Humoral and Cellular Immunity Following SARS-CoV-2 Vaccination in ANCA-Associated Vasculitis Patients Receiving B-Cell Depleting Therapy.接受B细胞清除疗法的抗中性粒细胞胞浆抗体相关性血管炎患者接种新型冠状病毒疫苗后的抗原特异性体液免疫和细胞免疫
Front Immunol. 2022 Jan 28;13:834981. doi: 10.3389/fimmu.2022.834981. eCollection 2022.
9
Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination.1273-mRNA 新冠病毒疫苗接种后长期血液透析患者中产生强烈细胞和体液免疫应答。
Front Immunol. 2022 Mar 23;13:845882. doi: 10.3389/fimmu.2022.845882. eCollection 2022.
10
T follicular helper cells in the humoral immune response to SARS-CoV-2 infection and vaccination.T 滤泡辅助细胞在 SARS-CoV-2 感染和疫苗接种的体液免疫反应中的作用。
J Leukoc Biol. 2022 Feb;111(2):355-365. doi: 10.1002/JLB.5MR0821-464R. Epub 2021 Nov 3.

引用本文的文献

1
Mannan-Decorated Lipid Calcium Phosphate Nanoparticle Vaccine Increased the Antitumor Immune Response by Modulating the Tumor Microenvironment.甘露糖修饰的脂质磷酸钙纳米颗粒疫苗通过调节肿瘤微环境增强抗肿瘤免疫反应。
J Funct Biomater. 2024 Aug 16;15(8):229. doi: 10.3390/jfb15080229.
2
UPO Biobank: The Challenge of Integrating Biobanking into the Academic Environment to Support Translational Research.UPO生物样本库：将生物样本库融入学术环境以支持转化研究的挑战。
J Pers Med. 2023 May 29;13(6):911. doi: 10.3390/jpm13060911.
3
Reply to Çınar et al. Comment on "Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. 2022, , 874".回复 Çınar 等人对“Zamfir 等人。在 mRNA COVID-19 疫苗接种运动的背景下诊断出的血液系统恶性肿瘤：两例报告。2022 年，，874”的评论。
Medicina (Kaunas). 2022 Nov 1;58(11):1576. doi: 10.3390/medicina58111576.